Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Brooklyn › NPI 1679565063
Physician

Hedayatnia, Mehrdad

Hedayatnia, Mehrdad was paid $807K by Medicaid between Jan 2018 and Nov 2024, across 20 billing codes. Its largest line is 64484, — 26% of everything it billed.

33Billing provider infoHEDAYATNIA, MEHRDAD
BROOKLYN, NY 11209
33aNPI1679565063assigned 08/22/2005
33bProvider typeAnesthesiology Physician
28Total paid$807K
24GClaims13,526
24DCodes billed20
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Anesthesiology Physician providers in New York

Rank by total paid#35 of 493
Median peer was paid$8K
This provider vs. median105×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,336$220K
20193,227$290K
20202,357$102K
20212,589$93K
20221,050$32K
2023964$34K
2024incomplete1,003$37K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
64484 26% 1,014 967 $212K
64483 18% 1,011 964 $145K
62323 13% 1,859 1,835 $107K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.7% 2,236 2,151 $71K
64635 8.7% 389 384 $70K
64636 6.8% 422 358 $55K
27096 3.8% 448 336 $31K
J1030 Injection, methylprednisolone acetate, 40 mg 2.5% 2,971 2,633 $20K
20610 2.2% 914 719 $18K
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg 2.2% 45 24 $18K
62321 2.1% 246 245 $17K
64493 1.6% 214 184 $13K
8 more codes
99203 Doctor's office visit, new patient (routine) 1.2% 212 $10K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.1% 742 $9K
64494 <1% 215 $7K
99442 <1% 47 $2K
64495 <1% 29 $2K
64615 <1% 26 $948.12
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 43 $803.36
99000 0% 443 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.